vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and VALMONT INDUSTRIES INC (VMI). Click either name above to swap in a different company.

VALMONT INDUSTRIES INC is the larger business by last-quarter revenue ($1.0B vs $749.2M, roughly 1.4× CLOVER HEALTH INVESTMENTS, CORP.). VALMONT INDUSTRIES INC runs the higher net margin — 16.2% vs 3.6%, a 12.5% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 0.1%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 3.0%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Valmont Industries, Inc. is a large, publicly held American manufacturer of Valley center pivot and linear irrigation equipment, windmill support structures, lighting and traffic poles and steel utility poles.

CLOV vs VMI — Head-to-Head

Bigger by revenue
VMI
VMI
1.4× larger
VMI
$1.0B
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+62.0% gap
CLOV
62.0%
0.1%
VMI
Higher net margin
VMI
VMI
12.5% more per $
VMI
16.2%
3.6%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
3.0%
VMI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLOV
CLOV
VMI
VMI
Revenue
$749.2M
$1.0B
Net Profit
$27.3M
$168.0M
Gross Margin
29.8%
Operating Margin
3.6%
11.2%
Net Margin
3.6%
16.2%
Revenue YoY
62.0%
0.1%
Net Profit YoY
116.3%
EPS (diluted)
$0.05
$9.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
VMI
VMI
Q1 26
$749.2M
Q4 25
$487.7M
$1.0B
Q3 25
$496.6M
$1.0B
Q2 25
$477.6M
$1.1B
Q1 25
$462.3M
$969.3M
Q4 24
$337.0M
$1.0B
Q3 24
$331.0M
$1.0B
Q2 24
$356.3M
$1.0B
Net Profit
CLOV
CLOV
VMI
VMI
Q1 26
$27.3M
Q4 25
$-49.3M
$168.0M
Q3 25
$-24.4M
$99.0M
Q2 25
$-10.6M
$-4.0M
Q1 25
$-1.3M
$87.3M
Q4 24
$-22.1M
$77.7M
Q3 24
$-9.2M
$83.1M
Q2 24
$7.4M
$99.7M
Gross Margin
CLOV
CLOV
VMI
VMI
Q1 26
Q4 25
29.8%
Q3 25
30.4%
Q2 25
30.6%
Q1 25
30.0%
Q4 24
30.2%
Q3 24
24.5%
29.6%
Q2 24
30.3%
30.8%
Operating Margin
CLOV
CLOV
VMI
VMI
Q1 26
3.6%
Q4 25
-10.1%
11.2%
Q3 25
-4.9%
13.5%
Q2 25
-2.2%
2.8%
Q1 25
-0.3%
13.2%
Q4 24
-6.4%
11.6%
Q3 24
-2.7%
12.3%
Q2 24
2.0%
14.2%
Net Margin
CLOV
CLOV
VMI
VMI
Q1 26
3.6%
Q4 25
-10.1%
16.2%
Q3 25
-4.9%
9.5%
Q2 25
-2.2%
-0.4%
Q1 25
-0.3%
9.0%
Q4 24
-6.6%
7.5%
Q3 24
-2.8%
8.1%
Q2 24
2.1%
9.6%
EPS (diluted)
CLOV
CLOV
VMI
VMI
Q1 26
$0.05
Q4 25
$9.02
Q3 25
$4.98
Q2 25
$-1.53
Q1 25
$4.32
Q4 24
$3.85
Q3 24
$4.11
Q2 24
$4.91

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
VMI
VMI
Cash + ST InvestmentsLiquidity on hand
$177.6M
$187.1M
Total DebtLower is stronger
$795.7M
Stockholders' EquityBook value
$339.4M
$1.6B
Total Assets
$697.7M
$3.4B
Debt / EquityLower = less leverage
0.49×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
VMI
VMI
Q1 26
$177.6M
Q4 25
$78.3M
$187.1M
Q3 25
$226.1M
Q2 25
$208.5M
Q1 25
$184.4M
Q4 24
$194.5M
$164.3M
Q3 24
$288.0M
$200.5M
Q2 24
$254.8M
$163.1M
Total Debt
CLOV
CLOV
VMI
VMI
Q1 26
Q4 25
$795.7M
Q3 25
Q2 25
Q1 25
Q4 24
$730.6M
Q3 24
Q2 24
Stockholders' Equity
CLOV
CLOV
VMI
VMI
Q1 26
$339.4M
Q4 25
$308.7M
$1.6B
Q3 25
$340.9M
$1.6B
Q2 25
$344.2M
$1.5B
Q1 25
$336.1M
$1.6B
Q4 24
$341.1M
$1.5B
Q3 24
$342.2M
$1.5B
Q2 24
$324.9M
$1.5B
Total Assets
CLOV
CLOV
VMI
VMI
Q1 26
$697.7M
Q4 25
$541.0M
$3.4B
Q3 25
$559.7M
$3.4B
Q2 25
$575.0M
$3.3B
Q1 25
$583.7M
$3.4B
Q4 24
$580.7M
$3.3B
Q3 24
$653.0M
$3.5B
Q2 24
$674.2M
$3.5B
Debt / Equity
CLOV
CLOV
VMI
VMI
Q1 26
Q4 25
0.49×
Q3 25
Q2 25
Q1 25
Q4 24
0.47×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
VMI
VMI
Operating Cash FlowLast quarter
$111.2M
Free Cash FlowOCF − Capex
$70.4M
FCF MarginFCF / Revenue
6.8%
Capex IntensityCapex / Revenue
3.9%
Cash ConversionOCF / Net Profit
0.66×
TTM Free Cash FlowTrailing 4 quarters
$311.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
VMI
VMI
Q1 26
Q4 25
$-66.9M
$111.2M
Q3 25
$12.1M
$112.5M
Q2 25
$5.4M
$167.6M
Q1 25
$-16.3M
$65.1M
Q4 24
$34.8M
$193.4M
Q3 24
$50.0M
$225.1M
Q2 24
$44.8M
$130.8M
Free Cash Flow
CLOV
CLOV
VMI
VMI
Q1 26
Q4 25
$-69.0M
$70.4M
Q3 25
$11.4M
$70.6M
Q2 25
$4.8M
$135.6M
Q1 25
$-16.5M
$34.8M
Q4 24
$33.3M
$167.8M
Q3 24
$49.6M
$204.6M
Q2 24
$44.4M
$112.5M
FCF Margin
CLOV
CLOV
VMI
VMI
Q1 26
Q4 25
-14.1%
6.8%
Q3 25
2.3%
6.7%
Q2 25
1.0%
12.9%
Q1 25
-3.6%
3.6%
Q4 24
9.9%
16.2%
Q3 24
15.0%
20.1%
Q2 24
12.5%
10.8%
Capex Intensity
CLOV
CLOV
VMI
VMI
Q1 26
Q4 25
0.4%
3.9%
Q3 25
0.1%
4.0%
Q2 25
0.1%
3.0%
Q1 25
0.0%
3.1%
Q4 24
0.5%
2.5%
Q3 24
0.1%
2.0%
Q2 24
0.1%
1.8%
Cash Conversion
CLOV
CLOV
VMI
VMI
Q1 26
Q4 25
0.66×
Q3 25
1.14×
Q2 25
Q1 25
0.75×
Q4 24
2.49×
Q3 24
2.71×
Q2 24
6.04×
1.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

VMI
VMI

Utility Product Line$424.5M41%
Lighting And Transportation$204.6M20%
Irrigation Equipment And Parts Excluding Technology$199.0M19%
Services$113.6M11%
Telecommunications$73.8M7%
Technology Products And Services$23.7M2%

Related Comparisons